A risk-scoring model for the differential diagnosis of lentigo maligna and other atypical pigmented facial lesions of the face: The facial iDScore.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
02
02
2023
accepted:
07
07
2023
medline:
26
10
2023
pubmed:
19
7
2023
entrez:
19
7
2023
Statut:
ppublish
Résumé
Due to progressive ageing of the population, the incidence of facial lentigo maligna (LM) of the face is increasing. Many benign simulators of LM and LMM, known as atypical pigmented facial lesions (aPFLs-pigmented actinic keratosis, solar lentigo, seborrheic keratosis, seborrheic-lichenoid keratosis, atypical nevus) may be found on photodamaged skin. This generates many diagnostic issues and increases the number of biopsies, with a subsequent impact on aesthetic outcome and health insurance costs. Our aim was to develop a risk-scoring classifier-based algorithm to estimate the probability of an aPFL being malignant. A second aim was to compare its diagnostic accuracy with that of dermoscopists so as to define the advantages of using the model in patient management. A total of 154 dermatologists analysed 1111 aPFLs and their management in a teledermatology setting: They performed pattern analysis, gave an intuitive clinical diagnosis and proposed lesion management options (follow-up/reflectance confocal microscopy/biopsy). Each case was composed of a dermoscopic and/or clinical picture plus metadata (histology, age, sex, location, diameter). The risk-scoring classifier was developed and tested on this dataset and then validated on 86 additional aPFLs. The facial Integrated Dermoscopic Score (iDScore) model consisted of seven dermoscopic variables and three objective parameters (diameter ≥ 8 mm, age ≥ 70 years, male sex); the score ranged from 0 to 16. In the testing set, the facial iDScore-aided diagnosis was more accurate (AUC = 0.79 [IC 95% 0.757-0.843]) than the intuitive diagnosis proposed by dermatologists (average of 43.5%). In the management study, the score model reduced the number of benign lesions sent for biopsies by 41.5% and increased the number of LM/LMM cases sent for reflectance confocal microscopy or biopsy instead of follow-up by 66%. The facial iDScore can be proposed as a feasible tool for managing patients with aPFLs.
Sections du résumé
BACKGROUND
BACKGROUND
Due to progressive ageing of the population, the incidence of facial lentigo maligna (LM) of the face is increasing. Many benign simulators of LM and LMM, known as atypical pigmented facial lesions (aPFLs-pigmented actinic keratosis, solar lentigo, seborrheic keratosis, seborrheic-lichenoid keratosis, atypical nevus) may be found on photodamaged skin. This generates many diagnostic issues and increases the number of biopsies, with a subsequent impact on aesthetic outcome and health insurance costs.
OBJECTIVES
OBJECTIVE
Our aim was to develop a risk-scoring classifier-based algorithm to estimate the probability of an aPFL being malignant. A second aim was to compare its diagnostic accuracy with that of dermoscopists so as to define the advantages of using the model in patient management.
MATERIALS AND METHODS
METHODS
A total of 154 dermatologists analysed 1111 aPFLs and their management in a teledermatology setting: They performed pattern analysis, gave an intuitive clinical diagnosis and proposed lesion management options (follow-up/reflectance confocal microscopy/biopsy). Each case was composed of a dermoscopic and/or clinical picture plus metadata (histology, age, sex, location, diameter). The risk-scoring classifier was developed and tested on this dataset and then validated on 86 additional aPFLs.
RESULTS
RESULTS
The facial Integrated Dermoscopic Score (iDScore) model consisted of seven dermoscopic variables and three objective parameters (diameter ≥ 8 mm, age ≥ 70 years, male sex); the score ranged from 0 to 16. In the testing set, the facial iDScore-aided diagnosis was more accurate (AUC = 0.79 [IC 95% 0.757-0.843]) than the intuitive diagnosis proposed by dermatologists (average of 43.5%). In the management study, the score model reduced the number of benign lesions sent for biopsies by 41.5% and increased the number of LM/LMM cases sent for reflectance confocal microscopy or biopsy instead of follow-up by 66%.
CONCLUSIONS
CONCLUSIONS
The facial iDScore can be proposed as a feasible tool for managing patients with aPFLs.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2301-2310Informations de copyright
© 2023 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
Iznardo H, Garcia-Melendo C, Yélamos O. Lentigo maligna: clinical presentation and appropriate management. Clin Cosmet Investig Dermatol. 2020;13:837-855.
Naik PP. Diagnosis and management of lentigo maligna: clinical presentation and comprehensive review. J Skin Cancer. 2021;2021:7178305.
Moreno A, Manrique-Silva E, Virós A, Requena C, Sanmartín O, Traves V, et al. Histologic features associated with an invasive component in lentigo Maligna lesions. JAMA Dermatol. 2019;155(7):782-788. https://doi.org/10.1001/jamadermatol.2019.0467
Gérard E, Cogrel O, Goehrs C, Guillot P, Ricard A, Pham-Ledard A, et al. Clinical features associated with the invasive component in lentigo maligna of the head and neck: a retrospective study of 175 cases. Ann Dermatol Venereol. 2022;149(4):258-263.
Dika E, Lambertini M, Patrizi A, Misciali C, Scarfì F, Pellacani G, et al. Folliculotropism in head and neck lentigo maligna and lentigo maligna melanoma. J Dtsch Dermatol Ges. 2020;19:223-229.
Tiodorovic-Zivkovic D, Argenziano G, Lallas A, Thomas L, Ignjatovic A, Rabinovitz H, et al. Age, gender, and topography influence the clinical and dermoscopic appearance of lentigo maligna. J Am Acad Dermatol. 2015;72(5):801-808.
Ferrara G, Ligrone L, Zalaudek I, Mordente I, Argenziano G. Lentigo maligna in a young adult. Dermatology. 2008;217(1):66-68.
Duarte AF, Sousa-Pinto B, Barros AM, Haneke E, Correia O. Lentigo Maligna - not always a face and neck disease of the elderly. Dermatology. 2018;234(1-2):37-42. https://doi.org/10.1159/000489397
Carapeba A, de Oliveira LM, Alves Pineze M, Alborghetti NG. Is dermoscopy a good tool for the diagnosis of lentigo maligna and lentigo maligna melanoma? A meta-analysis. Clin Cosmet Investig Dermatol. 2019;12:403-414.
Schiffner RB, Schiffner-Rohe J, Vogt T, Landthaler M, Wlotzke U, Cognetta AB, et al. Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol. 2000;42(1 Pt 1):25-32.
Fensterseifer GS, Lodi AP, Dantas ML, Boff AL, Lovatto L. Lentigo Maligna of the face: the importance of clinical, dermoscopic, and histological correlation. Dermatol Pract Concept. 2019;9(4):292-294.
Stolz W, Schiffner R, Burgdorf WH. Dermatoscopy for facial pigmented skin lesions. Clin Dermatol. 2002;20(3):276-278.
Lallas A, Argenziano G, Moscarella E, Longo C, Simonetti V, Zalaudek I. Diagnosis and management of facial pigmented macules. Clin Dermatol. 2014;32(1):94-100.
Costa-Silva M, Calistru A, Barros AM, Lopes S, Esteves M, Azevedo F. Dermatoscopy of flat pigmented facial lesions-evolution of lentigo maligna diagnostic criteria. Dermatol Pract Concept. 2018;8(3):198-203.
Pralong P, Bathelier E, Dalle S, Poulalhon N, Debarbieux S, Thomas L, et al. Dermoscopy of lentigo maligna melanoma: report of 125 cases. Br J Dermatol. 2012;167(2):280-287.
Bollea-Garlatti LA, Galimberti GN, Galimberti RL. Lentigo maligna: keys to dermoscopic diagnosis. Actas Dermosifiliogr. 2016;107(6):489-497.
Witta S, Bershow A, Farah RS, Berg B, Goldfarb N. Dermoscopy findings of a one mm lentigo maligna. Dermatol Online J. 2018;24(7):13030/qt5xp740wn.
Şahin MT, Öztürkcan S, Ermertcan AT, Güneş AT. A comparison of dermoscopic features among lentigo senilis/initial seborrheic keratosis, seborrheic keratosis, lentigo maligna and lentigo maligna melanoma on the face. J Dermatol. 2004;31(11):884-889.
Akay BN, Kocyigit P, Heper AO, Erdem C. Dermatoscopy of flat pigmented facial lesions: diagnostic challenge between pigmented actinic keratosis and lentigo maligna. Br J Dermatol. 2010;163(6):1212-1217.
Tanaka M, Sawada M, Kobayashi K. Key points in dermoscopic differentiation between lentigo maligna and solar lentigo. J Dermatol. 2011;38(1):53-58.
Lallas A, Tschandl P, Kyrgidis A, Stolz W, Rabinovitz H, Cameron A, et al. Dermoscopic clues to differentiate facial lentigo maligna from pigmented actinic keratosis. Br J Dermatol. 2016;174(5):1079-1085.
Ozbagcivan O, Akarsu S, Ikiz N, Semiz F, Fetil E. Dermoscopic differentiation of facial lentigo Maligna from pigmented actinic keratosis and solar lentigines. Acta Dermatovenerol Croat. 2019;27(3):146-152.
Mazzei ME. Is it solar lentigo or lentigo Maligna? (it is not a nevus). Actas Dermosifiliogr. 2016;107(6):451-453.
Zalaudek I, Cota C, Ferrara G, Moscarella E, Guitera P, Longo C, et al. Flat pigmented macules on sun-damaged skin of the head/neck: junctional nevus, atypical lentiginous nevus, or melanoma in situ? Clin Dermatol. 2014;32(1):88-93.
Zoutendijk J, Koljenovic S, Wakkee M, Mooyaart AL, Nijsten T, van den Bos RR. Clinical findings are not helpful in detecting lentigo maligna melanoma in patients with biopsy-proven lentigo maligna. J Eur Acad Dermatol Venereol. 2022;36(12):2325-2330.
DeWane ME, Kelsey A, Oliviero M, Rabinovitz H, Grant-Kels JM. Melanoma on chronically sun-damaged skin: lentigo maligna and desmoplastic melanoma. J Am Acad Dermatol. 2019;81(3):823-833.
Tognetti L, Cinotti E, Farnetani F, Lallas A, Paoli J, Longo C, et al. Development and implementation of a web-based international registry dedicated to atypical pigmented skin lesions of the face: teledermatologic investigation on epidemiology and risk factors. Telemed J E Health. 2023. https://doi.org/10.1089/tmj.2022.0456
Pellacani G, Farnetani F, Ciardo S, Chester J, Kaleci S, Mazzoni L, et al. Effect of reflectance confocal microscopy for suspect lesions on diagnostic accuracy in melanoma: a randomized clinical trial. JAMA Dermatol. 2022;158(7):754-761.
Tognetti L, Cartocci A, Balistreri A, Cataldo G, Cinotti E, Moscarella E, et al. The comparative use of multiple electronic devices in the Teledermoscopic diagnosis of early melanoma. Telemed J E Health. 2021;27(5):495-502.
Xiong M, Charifa A, Chen CSJ. Lentigo maligna melanoma. StatPearls [internet]. Treasure Island, FL: StatPearls Publishing; 2022 Available from: https://www.ncbi.nlm.nih.gov/books/NBK482163/ [Updated 2022 Oct 31]
Nelson KC, Swetter SM, Saboda K, Chen SC, Curiel-Lewandrowski C. Evaluation of the number-needed-to-biopsy metric for the diagnosis of cutaneous melanoma: a systematic review and meta-analysis. JAMA Dermatol. 2019;155(10):1167-1174.
Star P, Guitera P. Lentigo maligna, macules of the face, and lesions on sun-damaged skin: confocal makes the difference. Dermatol Clin. 2016;34(4):421-429. https://doi.org/10.1016/j.det.2016.05.005
Mataca E, Migaldi M, Cesinaro AM. Impact of dermoscopy and reflectance confocal microscopy on the histopathologic diagnosis of lentigo maligna/lentigo maligna melanoma. Am J Dermatopathol. 2018;40(12):884-889. https://doi.org/10.1097/DAD.0000000000001212
Cinotti E, Fiorani D, Labeille B, Gonzalez S, Debarbieux S, Agozzino M, et al. The integration of dermoscopy and reflectance confocal microscopy improves the diagnosis of lentigo maligna. J Eur Acad Dermatol Venereol. 2019;33(10):e372-e374.
Marchetti MA, Yu A, Nanda J, Tschandl P, Kittler H, Marghoob AA, et al. Number needed to biopsy ratio and diagnostic accuracy for melanoma detection. J Am Acad Dermatol. 2020;83(3):780-787.
Tognetti L, Cartocci A, Cinotti E, Moscarella E, Farnetani F, Carrera C, et al. Dermoscopy of early melanomas: variation according to the anatomic site. Arch Dermatol Res. 2022;314(2):183-190.
Micantonio T, Neri L, Longo C, Grassi S, di Stefani A, Antonini A, et al. A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosis. Eur J Dermatol. 2018;28(2):162-168.
Tognetti L, Cevenini G, Moscarella E, Cinotti E, Farnetani F, Mahlvey J, et al. An integrated clinical-dermoscopic risk scoring system for the differentiation between early melanoma and atypical nevi: the iDScore. J Eur Acad Dermatol Venereol. 2018;32(12):2162-2170.
Rubegni P, Tognetti L, Argenziano G, Nami N, Brancaccio G, Cinotti E, et al. A risk scoring system for the differentiation between melanoma with regression and regressing nevi. J Dermatol Sci. 2016;83(2):138-144.
Tognetti L, Cartocci A, Bertello M, Giordani M, Cinotti E, Cevenini G, et al. An updated algorithm integrated with patient data for the differentiation of atypical nevi from early melanomas: the idScore 2021. Dermatol Pract Concep. 2022;12:e2022134.
Tognetti L, Cevenini G, Moscarella E, Cinotti E, Farnetani F, Lallas A, et al. Validation of an integrated dermoscopic scoring method in an European teledermoscopy web platform: the iDScore project for early detection of melanoma. J Eur Acad Dermatol Venereol. 2020;34(3):640-647.
Lallas A, Lallas K, Tschandl P, Kittler H, Apalla Z, Longo C, et al. The dermoscopic inverse approach significantly improves the accuracy of human readers for lentigo maligna diagnosis. J Am Acad Dermatol. 2021;84(2):381-389.
Tschandl P, Rinner C, Apalla Z, Argenziano G, Codella N, Halpern A, et al. Human-computer collaboration for skin cancer recognition. Nat Med. 2020;26:1229-1234.
Stiff KM, Franklin MJ, Zhou Y, Madabhushi A, Knackstedt TJ. Artificial intelligence and melanoma: a comprehensive review of clinical, dermoscopic, and histologic applications. Pigment Cell Melanoma Res. 2022;35(2):203-211.
Tognetti L, Bonechi S, Andreini P, Bianchini M, Scarselli F, Cevenini G, et al. A new deep learning approach integrated with clinical data for the dermoscopic differentiation of early melanomas from atypical nevi. J Dermatol Sci. 2021;101(2):115-122.
Tognetti L, Cartocci A, Cinotti E, Moscarella E, Farnetani F, Lallas A, et al. The impact of anatomical location and sun exposure on the dermoscopic recognition of atypical nevi and early melanomas: usefulness of an integrated clinical-dermoscopic method (iDScore). J Eur Acad Dermatol Venereol. 2021;35(3):650-657.